HALO:BMV
Halozyme Therapeutics, Inc.
MX$1,955.00
arrow_downward
-0.70%(-13.69) 1D
Oct 1, 1:46:16 PM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HALO...
Mkt. cap
12.72B
Avg. vol.
440.00
Volume
0.00
52-wk high
MX$1,970.00
52-wk low
MX$1,126.00
No. of employees
423
Mkt. cap
12.72B
Avg. vol.
440.00
Volume
0.00
52-wk high
MX$1,970.00
52-wk low
MX$1,126.00
No. of employees
423
News stories
From web sources and news partners
ChartMill
·
3 days ago
Halozyme Therapeutics (NASDAQ:HALO): A Decent Value Stock With Strong Profitability
https://www.dars.gov.et/
·
5 days ago
Halozyme Therapeutics (HALO) Edges Higher as Shares Hold Above Key Support - Dealer Gamma
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees423
Founded1998
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websitehalozyme.com